Literature DB >> 28740607

Crystal Structure of a Human K-Ras G12D Mutant in Complex with GDP and the Cyclic Inhibitory Peptide KRpep-2d.

Satoshi Sogabe1, Yusuke Kamada1, Masanori Miwa1, Ayumu Niida1, Tomoya Sameshima1, Masahiro Kamaura1, Kazuko Yonemori1, Shigekazu Sasaki1, Jun-Ichi Sakamoto1, Kotaro Sakamoto1.   

Abstract

The Ras proteins play roles in cell differentiation, proliferation, and survival. Aberrant signaling through Ras-mediated pathways in tumor cells occurs as a result of several types of mutational damage, which most frequently affects the amino acids G12, G13, and Q61. Recently, KRpep-2d was identified as a K-Ras(G12D) selective inhibitory peptide against the G12D mutant of K-Ras, which is a key member of the Ras protein family and an attractive cancer therapeutic target. In this study, the crystal structure of the human K-Ras(G12D) mutant was determined in complex with GDP and KRpep-2d at 1.25 Å resolution. This structure revealed that the peptide binds near Switch II and allosterically blocks protein-protein interactions with the guanine nucleotide exchange factor. This discovery of a unique binding pocket provides valuable information that will facilitate the design of direct Ras inhibitors.

Entities:  

Keywords:  G12D mutation; K-Ras; X-ray crystallography; inhibitor; peptide; protein−protein interaction

Year:  2017        PMID: 28740607      PMCID: PMC5512123          DOI: 10.1021/acsmedchemlett.7b00128

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  25 in total

Review 1.  Drugging the undruggable RAS: Mission possible?

Authors:  Adrienne D Cox; Stephen W Fesik; Alec C Kimmelman; Ji Luo; Channing J Der
Journal:  Nat Rev Drug Discov       Date:  2014-10-17       Impact factor: 84.694

Review 2.  The renaissance of Ras.

Authors:  Lech-Gustav Milroy; Christian Ottmann
Journal:  ACS Chem Biol       Date:  2014-09-23       Impact factor: 5.100

3.  Direct inhibition of oncogenic KRAS by hydrocarbon-stapled SOS1 helices.

Authors:  Elizaveta S Leshchiner; Andrey Parkhitko; Gregory H Bird; James Luccarelli; Joseph A Bellairs; Silvia Escudero; Kwadwo Opoku-Nsiah; Marina Godes; Norbert Perrimon; Loren D Walensky
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-26       Impact factor: 11.205

Review 4.  Small-molecule modulation of Ras signaling.

Authors:  Jochen Spiegel; Philipp M Cromm; Gunther Zimmermann; Tom N Grossmann; Herbert Waldmann
Journal:  Nat Chem Biol       Date:  2014-06-15       Impact factor: 15.040

5.  Investigation of the structural requirements of K-Ras(G12D) selective inhibitory peptide KRpep-2d using alanine scans and cysteine bridging.

Authors:  Ayumu Niida; Shigekazu Sasaki; Kazuko Yonemori; Tomoya Sameshima; Masahiro Yaguchi; Taiji Asami; Kotaro Sakamoto; Masahiro Kamaura
Journal:  Bioorg Med Chem Lett       Date:  2017-04-21       Impact factor: 2.823

6.  Approach for targeting Ras with small molecules that activate SOS-mediated nucleotide exchange.

Authors:  Michael C Burns; Qi Sun; R Nathan Daniels; DeMarco Camper; J Phillip Kennedy; Jason Phan; Edward T Olejniczak; Taekyu Lee; Alex G Waterson; Olivia W Rossanese; Stephen W Fesik
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

7.  In silico discovery of small-molecule Ras inhibitors that display antitumor activity by blocking the Ras-effector interaction.

Authors:  Fumi Shima; Yoko Yoshikawa; Min Ye; Mitsugu Araki; Shigeyuki Matsumoto; Jingling Liao; Lizhi Hu; Takeshi Sugimoto; Yuichi Ijiri; Azusa Takeda; Yuko Nishiyama; Chie Sato; Shin Muraoka; Atsuo Tamura; Tsutomu Osoda; Ken-ichiro Tsuda; Tomoya Miyakawa; Hiroaki Fukunishi; Jiro Shimada; Takashi Kumasaka; Masaki Yamamoto; Tohru Kataoka
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-29       Impact factor: 11.205

8.  An orthosteric inhibitor of the Ras-Sos interaction.

Authors:  Anupam Patgiri; Kamlesh K Yadav; Paramjit S Arora; Dafna Bar-Sagi
Journal:  Nat Chem Biol       Date:  2011-07-17       Impact factor: 15.040

9.  A comprehensive survey of Ras mutations in cancer.

Authors:  Ian A Prior; Paul D Lewis; Carla Mattos
Journal:  Cancer Res       Date:  2012-05-15       Impact factor: 12.701

10.  Discovery of small molecules that bind to K-Ras and inhibit Sos-mediated activation.

Authors:  Qi Sun; Jason P Burke; Jason Phan; Michael C Burns; Edward T Olejniczak; Alex G Waterson; Taekyu Lee; Olivia W Rossanese; Stephen W Fesik
Journal:  Angew Chem Int Ed Engl       Date:  2012-05-08       Impact factor: 15.336

View more
  16 in total

1.  Accelerated Identification of Cell Active KRAS Inhibitory Macrocyclic Peptides using Mixture Libraries and Automated Ligand Identification System (ALIS) Technology.

Authors:  Michael Garrigou; Bérengère Sauvagnat; Ruchia Duggal; Nicole Boo; Pooja Gopal; Jennifer M Johnston; Anthony Partridge; Tomi Sawyer; Kaustav Biswas; Nicolas Boyer
Journal:  J Med Chem       Date:  2022-06-15       Impact factor: 8.039

2.  RAS-inhibiting biologics identify and probe druggable pockets including an SII-α3 allosteric site.

Authors:  Katarzyna Z Haza; Heather L Martin; Ajinkya Rao; Amy L Turner; Sophie E Saunders; Britta Petersen; Christian Tiede; Kevin Tipping; Anna A Tang; Modupe Ajayi; Thomas Taylor; Maia Harvey; Keri M Fishwick; Thomas L Adams; Thembaninkosi G Gaule; Chi H Trinh; Matthew Johnson; Alexander L Breeze; Thomas A Edwards; Michael J McPherson; Darren C Tomlinson
Journal:  Nat Commun       Date:  2021-06-30       Impact factor: 14.919

3.  Bifunctional Small-Molecule Ligands of K-Ras Induce Its Association with Immunophilin Proteins.

Authors:  Ziyang Zhang; Kevan M Shokat
Journal:  Angew Chem Int Ed Engl       Date:  2019-09-26       Impact factor: 16.823

Review 4.  Targeting the Small GTPase Superfamily through Their Regulatory Proteins.

Authors:  Janine L Gray; Frank von Delft; Paul E Brennan
Journal:  Angew Chem Int Ed Engl       Date:  2020-01-30       Impact factor: 16.823

Review 5.  The multifunctional role of phospho-calmodulin in pathophysiological processes.

Authors:  Antonio Villalobo
Journal:  Biochem J       Date:  2018-12-21       Impact factor: 3.857

6.  From basic researches to new achievements in therapeutic strategies of KRAS-driven cancers.

Authors:  Mahsa Saliani; Razieh Jalal; Mohammad Reza Ahmadian
Journal:  Cancer Biol Med       Date:  2019-08       Impact factor: 4.248

Review 7.  Structure-based inhibitor design of mutant RAS proteins-a paradigm shift.

Authors:  Kinga Nyíri; Gergely Koppány; Beáta G Vértessy
Journal:  Cancer Metastasis Rev       Date:  2020-12       Impact factor: 9.264

8.  Generation of KS-58 as the first K-Ras(G12D)-inhibitory peptide presenting anti-cancer activity in vivo.

Authors:  Kotaro Sakamoto; Teruaki Masutani; Takatsugu Hirokawa
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

9.  Single-chain tandem macrocyclic peptides as a scaffold for growth factor and cytokine mimetics.

Authors:  Kenichiro Ito; Yoshihiko Matsuda; Ayako Mine; Natsuki Shikida; Kazutoshi Takahashi; Kyohei Miyairi; Kazutaka Shimbo; Yoshimi Kikuchi; Atsushi Konishi
Journal:  Commun Biol       Date:  2022-01-14

10.  GTP-State-Selective Cyclic Peptide Ligands of K-Ras(G12D) Block Its Interaction with Raf.

Authors:  Ziyang Zhang; Rong Gao; Qi Hu; Hayden Peacock; D Matthew Peacock; Shizhong Dai; Kevan M Shokat; Hiroaki Suga
Journal:  ACS Cent Sci       Date:  2020-09-23       Impact factor: 14.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.